Memede Manyetik Rezonans Görüntüleme
Özet
Meme MRG, meme görüntülemesinde önemli bir yer tutar ve mamografi, ultrasonografi ile birlikte kullanılarak meme kanseri tanısında yüksek duyarlılık sağlar. Özellikle preoperatif evreleme, post-operatif değerlendirme ve yüksek riskli kadınların taranmasında etkin bir yöntemdir. Manyetik rezonans görüntüleme, kontrast madde kullanarak damarların görünümünü artırır, bu da tümörlerin tespitini kolaylaştırır.
Neoadjuvan tedavi sonrası takipte, tedaviye yanıtı değerlendirmek için kullanılırken, meme rekonstrüksiyonu sonrasında da meme yapısının değerlendirilmesinde kritik bir rol oynar. Geleneksel görüntüleme yöntemlerinin gözden kaçırabileceği kanserleri tespit etme yeteneği, tedavi planlarının değişmesine neden olabilir. Genel olarak, Meme MRG, meme sağlığı alanında önemli bir araçtır ve erken teşhis ile daha etkili tedavi imkanı sunar.
Breast MRI plays a crucial role in breast imaging, providing high sensitivity for breast cancer diagnosis when used alongside mammography and ultrasound. It is particularly effective for preoperative staging, postoperative assessment, and screening high-risk women. Magnetic resonance imaging enhances the visibility of blood vessels through the use of contrast agents, facilitating the detection of tumors. In the follow-up after neoadjuvant therapy, it is employed to evaluate treatment response, and it also plays a critical role in assessing breast structure post-reconstruction. Its ability to identify cancers that may be missed by conventional imaging methods can lead to changes in treatment plans. Overall, breast MRI is an essential tool in breast health, offering the potential for early detection and more effective treatment options.
Referanslar
Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006; 24: 964-70.
Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008;18(7):1307–1318.
Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10(2):199–204.
Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989;170(3 Pt 1):681–686.
Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10(3):260–266.
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407(6801):249–257.
Rahbar H, Partridge SC. Multiparametric MR imaging of breast cancer. Magn Reson Imaging Clin N Am 2016;24(1):223–238.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-41.
Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005; 12: 1045-53.
Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010; 375: 563-71.
Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-58. 12. de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer 2006; 42: 351-6.
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345: 1378-87.
Preda L, Villa G, Rizzo S, Bazzi L, Origgi D, Cassano E, et al. Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 2006; 8: R53.
Belli P, Pastore G, Romani M, Terribile D, Canadè A, Costantini M. Role of magnetic resonance imaging in the diagnosis of recurrence after breast conserving therapy. Rays 2002; 27: 241-57.
Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004; 14: 1371-9.
Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10.
Belli P, Costantini M, Malaspina C, Magistrelli A, Latorre G, Bonomo L. MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy. Clin Radiol 2006; 61: 946-53.
Cao MD, Giskeødegård GF, Bathen TF, Sitter B, Bofin A, Lønning PE, et al. Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer 2012; 12: 39.
Richard R, Thomassin I, Chapellier M, Scemama A, de Cremoux P, Varna M, et al. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 2013; 23: 2420-31.
Julius T, Kemp SE, Kneeshaw PJ, Chaturvedi A, Drew PJ, Turnbull LW. MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 2005; 31: 1129-34.
Arpino G, Laucirica R, Elledge RM. Premalignant and InSitu Breast Disease: Biology and clinical implications. Annals of Internal Medicine. 2005;143(6):446.
Monticciolo DL et al. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J AmCollRadiol. 2017;14(9):1137-43.
Obdeijn IM, Winter-Warnars GA, Mann RM, Hooning MJ, Hunink MG, Tilanus Linthorst MM. Should we screen BRCA1 mutation carriers only with MRI ? A multicenter study. Breast Cancer Res Treat 2014;144(3):577-582.
Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol 2018;15(3):408-414.
DeMartini W, Lehman C. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19: 143-50.
Mann, R.M., Balleyguier, C., Baltzer, P.A. et al. Breast MRI: EUSOBI recommendations for women’s information. Eur Radiol 25, 3669–3678 (2015).
Sardanelli, F et al. (2010). Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. European journal of cancer, 46(8), 1296-1316.
Giess CS, Yeh ED, Raza S, Birdwell RL. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation. Radiographics 2014; 34: 234-47.
Ellis RL. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. AJR Am J Roentgenol 2009; 193: 1738-40.
Teifke A, Hlawatsch A, Beier T, Werner Vomweg T, Schadmand S, Schmidt M, et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 2002; 224: 881-8.
Shimauchi A, Jansen SA, Abe H, Jaskowiak N, Schmidt RA, Newstead GM. Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol 2010; 194: 1674-9.
D.A. Spak, J.S. Plaxco, L. Santiago, M.J. Dryden, B.E. Dogan. BIRADS Fifth Edition: A Summary of Changes. Diagnostic and Interventional Imaging 2017; 98, 3: 179-190.
Giess CS, Raza S, Birdwell RL. Patterns of non-masslike enhancement at screening breast MR imaging of high-risk premenopausal women. Radiographics 2013; 33: 1343-60.
Kuhl C. The Current Status of Breast MR Imaging Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice. Radiology 2007; 244:2, 356-378.
Kuhl C. The Current Status of Breast MR Imaging Part 2. Clinical Applications. Radiology 2007; 244:, 672-690.
